New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
16:00 EDTOPKOPKO citicoline products approved for commercialization in Spain
OPKO Health announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U., received regulatory approval from Spainís health authority for commercialization of its oral and injectable formulations of citicoline. Final marketing authorization is expected within 60 to 90 days.
News For OPK From The Last 14 Days
Check below for free stories on OPK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
10:42 EDTOPKOPKO Health granted RAYALDEE patent from USPTO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use